Holen Sie sich die Stockscreener-App
38.34
1.32%
0.50
Handel nachbörslich:
38.89
0.55
+1.43%
Schlusskurs vom Vortag:
$37.84
Offen:
$37.62
24-Stunden-Volumen:
778.43K
Relative Volume:
0.73
Marktkapitalisierung:
$2.13B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-22.55
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
-4.96%
1M Leistung:
-22.70%
6M Leistung:
-41.00%
1J Leistung:
-49.57%
1-Tages-Spanne:
$37.18
$38.47
1-Wochen-Bereich:
$37.18
$42.43
52-Wochen-Spanne:
$37.12
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
38.34 | 2.20B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Using AI based signals to follow PROCEPT BioRobotics CorporationExit Point & AI Enhanced Trading Alerts - Newser
Relative Strength Alert For PROCEPT BioRobotics - Nasdaq
PROCEPT BioRobotics Corporation stock daily chart insights2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - Newser
Using data tools to time your PROCEPT BioRobotics Corporation exitJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
What MACD signals say about PROCEPT BioRobotics CorporationJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Can PROCEPT BioRobotics Corporation hit a new high this monthInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Institutional scanner results for PROCEPT BioRobotics CorporationJobs Report & Growth Focused Investment Plans - Newser
Will PROCEPT BioRobotics Corporation bounce back from current support2025 Performance Recap & Entry Point Strategy Guides - Newser
Is PROCEPT BioRobotics Corporation building a consolidation baseWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Ranking PROCEPT BioRobotics Corporation among high performing stocks via tools2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Statistical indicators supporting PROCEPT BioRobotics Corporation’s strengthJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Real time social sentiment graph for PROCEPT BioRobotics CorporationDividend Hike & Smart Allocation Stock Reports - Newser
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionWeekly Stock Recap & High Accuracy Trade Alerts - Newser
What is the next catalyst for PROCEPT BioRobotics CorporationJuly 2025 Technicals & Stepwise Swing Trade Plans - khodrobank.com
Is PROCEPT BioRobotics Corporation trending in predictive chart modelsWall Street Watch & Weekly Top Gainers Trade List - Newser
Best data tools to analyze PROCEPT BioRobotics Corporation stockQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Short interest data insights for PROCEPT BioRobotics CorporationBull Run & Free Expert Approved Momentum Trade Ideas - Newser
PROCEPT BioRobotics Corporation stock retracement – recovery analysisTrade Signal Summary & Technical Pattern Alert System - Newser
Applying Elliott Wave Theory to PROCEPT BioRobotics CorporationEarnings Growth Summary & Entry and Exit Point Strategies - Newser
What’s the recovery path for long term holders of PROCEPT BioRobotics Corporation2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Procept Offers Attractive Risk-Reward, Oppenheimer Says - MarketScreener
Procept BioRobotics stock upgraded by Oppenheimer on attractive risk-reward - Investing.com
Procept BioRobotics upgraded to Outperform from Perform at Oppenheimer - TipRanks
Will PROCEPT BioRobotics Corporation stock go up soonDollar Strength & Reliable Intraday Trade Alerts - Newser
Oppenheimer Upgrades PROCEPT BioRobotics to Outperform From Market Perform, Price Target is $60 - MarketScreener
Using R and stats models for PROCEPT BioRobotics Corporation forecastingJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
What recovery options are there for PROCEPT BioRobotics Corporation2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Can PROCEPT BioRobotics Corporation reach all time highs this yearAnalyst Upgrade & Entry Point Confirmation Alerts - khodrobank.com
What are PROCEPT BioRobotics Corporation’s growth leversWeekly Market Report & Daily Stock Trend Watchlist - khodrobank.com
Will PROCEPT BioRobotics Corporation face regulatory challenges2025 Trading Recap & AI Forecasted Entry and Exit Points - khodrobank.com
Does PROCEPT BioRobotics Corporation stock reflect fundamentalsTrade Exit Summary & Entry Point Strategy Guides - khodrobank.com
Smart tools for monitoring PROCEPT BioRobotics Corporation’s price actionTreasury Yields & Technical Pattern Based Buy Signals - Newser
How cyclical is PROCEPT BioRobotics Corporation’s revenue streamJuly 2025 Setups & Momentum Based Trading Ideas - khodrobank.com
Is PROCEPT BioRobotics Corporation a candidate for recovery playMarket Activity Report & Safe Capital Allocation Plans - Newser
Will PROCEPT BioRobotics Corporation benefit from sector rotationQuarterly Market Summary & Daily Entry Point Trade Alerts - khodrobank.com
Volume spikes in PROCEPT BioRobotics Corporation stock – what they meanTrend Reversal & Fast Exit/Entry Strategy Plans - Newser
Volatility clustering patterns for PROCEPT BioRobotics CorporationWeekly Gains Report & AI Powered Market Trend Analysis - Newser
Will PROCEPT BioRobotics Corporation Benefit From Broader Market Bounce getLinesFromResByArray error: size == 0 - news-j.co.kr
Using data models to predict PROCEPT BioRobotics Corporation stock movementJuly 2025 Summary & Daily Price Action Insights - Newser
Analyzing PROCEPT BioRobotics Corporation with risk reward ratio chartsWeekly Trading Summary & Community Verified Trade Signals - Newser
Can momentum traders help lift PROCEPT BioRobotics CorporationBull Run & Fast Exit/Entry Strategy Plans - Newser
Published on: 2025-08-31 06:47:50 - Newser
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Procept Biorobotics Corp-Aktie (PRCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MOLL FREDERIC H | Director |
Aug 13 '25 |
Buy |
39.26 |
20,000 |
785,138 |
863,159 |
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Aug 14 '25 |
Option Exercise |
4.52 |
11,000 |
49,720 |
72,473 |
| Desai Antal Rohit | Director |
Jun 10 '25 |
Sale |
63.91 |
25,000 |
1,597,711 |
64,363 |
| Desai Antal Rohit | Director |
Jun 11 '25 |
Sale |
63.38 |
25,000 |
1,584,525 |
39,363 |
| Desai Antal Rohit | Director |
Jun 12 '25 |
Sale |
61.49 |
25,000 |
1,537,256 |
14,363 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):